Immunovant CTO Jay S. Stout sells shares at $32.06
The issuer-required sell-to-cover transactions addressed tax withholding tied to RSU vesting and were described as nondiscretionary.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Immunovant, Inc.’s Chief Technology Officer, Jay S. Stout, reported two direct sales of common stock on October 7, 2026: 2,213 shares and 1,596 shares, each at a weighted average price of $32.06 per share.
The sales were required by Immunovant to cover tax withholding related to RSU vesting and were not discretionary. No Rule 10b5-1 plan is reported.
Insider Trade Summary
Net Seller: 3,809 shares
Net Sell
2 txns
Insider
Stout Jay S
Role
Chief Technology Officer
Sold
3,809 shs ($122K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1, F2 | 2,213 | $32.06 | $71K |
| Sale | Common Stock F3, F2 | 1,596 | $32.06 | $51K |
Holdings After Transaction:
Common Stock — 201,532 shares (Direct)
Footnotes (3)
- F1. On April 1, 2025, the holder was granted 76,181 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on April 3, 2025, of which 4,761 of these RSUs vested on October 1, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- F2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.58 - $32.30 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- F3. On April 2, 2024, the holder was granted 54,978 RSUs, as previously reported on a Form 4 filed on April 4, 2024, of which 3,437 of these RSUs vested on October 2, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
Key Figures
Common shares sold: 2,213 shares
Common shares sold: 1,596 shares
Weighted average sale price: $32.06 per share
+3 more
6 metrics
Common shares sold
2,213 shares
Direct sale on October 7, 2026
Common shares sold
1,596 shares
Direct sale on October 7, 2026
Weighted average sale price
$32.06 per share
Both reported sales on October 7, 2026
RSUs vested
4,761 RSUs
Vested October 1, 2026
RSUs vested
3,437 RSUs
Vested October 2, 2026
Sale price range
$31.58–$32.30 per share
Inclusive range across multiple transactions
Key Terms
sell to cover, restricted stock units, weighted average price, tax withholding obligations
4 terms
sell to cover financial
"funded by a "sell to cover" transaction"
Sell to cover is when a person who receives company stock through options or awards sells just enough shares immediately to pay required taxes, exercise costs, or fees, keeping the rest. Think of it like cashing part of a bonus to cover the tax bill so you can keep the remainder. For investors, it can create predictable small selling pressure and slightly change the number of shares actually held by insiders without increasing long‑term dilution.
restricted stock units financial
"granted 76,181 restricted stock units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
weighted average price financial
"The price reported is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
tax withholding obligations financial
"to cover tax withholding obligations"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Which IMVT RSU vestings were associated with Jay S. Stout’s sales?
The sales were tied to 4,761 RSUs that vested October 1, 2026, and 3,437 RSUs that vested October 2, 2026. The related grants were 76,181 RSUs on April 1, 2025, and 54,978 RSUs on April 2, 2024.
AI-generated analysis. How Rhea-AI works. Not financial advice.
